Diabetes mellitus-associated vascular impairment: Novel circulating biomarkers and therapeutic approaches

Journal of the American College of Cardiology

Volumn 62, Issue 8, 2013, Pages 667-676

  Tousoulis, Dimitris ^a   Papageorgiou, Nikolaos ^a   Androulakis, Emmanuel ^a   Siasos, Gerasimos ^a   Latsios, George ^a   Tentolouris, Konstantinos ^a   Stefanadis, Christodoulos ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

biomarkers; diabetes mellitus; endothelium; vascular function

Indexed keywords

ACETYLCYSTEINE; ANTIDIABETIC AGENT; ARGININE; ATORVASTATIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CANDESARTAN; CARVEDILOL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLIBENCLAMIDE; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN DETEMIR; INSULIN GLARGINE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; LISINOPRIL; METFORMIN; METOPROLOL; MICRORNA; PLACEBO; PLASMINOGEN ACTIVATOR INHIBITOR 1; ROSIGLITAZONE; ROSUVASTATIN; SILDENAFIL; SIMVASTATIN; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

ARTICLE; BLOOD VESSEL FUNCTION; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DISEASE ASSOCIATION; DRUG RESPONSE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL MICROPARTICLE; HUMAN; INFLAMMATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TREATMENT OUTCOME;

EID: 84883312084     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.03.089     Document Type: Review

References (81)

1. D. Tousoulis, A.M. Kampoli, and C. Stefanadis Diabetes mellitus and vascular endothelial dysfunction: current perspectives Curr Vasc Pharmacol 10 2012 19 32
2. A.M. Kampoli, D. Tousoulis, A. Briasoulis, G. Latsios, N. Papageorgiou, and C. Stefanadis Potential pathogenic inflammatory mechanisms of endothelial dysfunction induced by type 2 diabetes mellitus Curr Pharm Des 17 2011 4147 4158
3. D. Tousoulis, A.M. Kampoli, C. Tentolouris, N. Papageorgiou, and C. Stefanadis The role of nitric oxide on endothelial function Curr Vasc Pharmacol 10 2012 4 18
4. D.H. Endemann, and E.L. Schiffrin Endothelial dysfunction J Am Soc Nephrol 15 2004 1983 1992
5. D. Tousoulis, K. Tsarpalis, D. Cokkinos, and C. Stefanadis Effects of insulin resistance on endothelial function: possible mechanisms and clinical implications Diabetes Obes Metab 10 2008 834 842
6. V.K. Capellini, A.C. Celotto, and C.F. Baldo Diabetes and vascular disease: basic concepts of nitric oxide physiology, endothelial dysfunction, oxidative stress and therapeutic possibilities Curr Vasc Pharmacol 8 2010 526 544
7. R. Nosadini, and G. Tonolo Role of oxidized low density lipoproteins and free fatty acids in the pathogenesis of glomerulopathy and tubulointerstitial lesions in type 2 diabetes Nutr Metab Cardiovasc Dis 21 2011 79 85
8. A.M. Kampoli, D. Tousoulis, A. Briasoulis, G. Latsios, N. Papageorgiou, and C. Stefanadis Potential pathogenic inflammatory mechanisms of endothelial dysfunction induced by type 2 diabetes mellitus Curr Pharm Des 17 2011 4147 4158
9. D. Tousoulis, G. Hatzis, and N. Papageorgiou Assessment of acute coronary syndromes: focus on novel biomarkers Curr Med Chem 19 2012 2572 2587
10. F. Hu, J.B. Meigs, T.Y. Li, N. Rifai, and J.E. Manson Inflammatory markers and risk of developing type 2 diabetes in women Diabetes 53 2004 693 700
11. C.W. Lin, L.A. Hsu, and C.C. Chen C-reactive protein as an outcome predictor for percutaneous transluminal angioplasty in diabetic patients with peripheral arterial disease and infected foot ulcers Diabetes Res Clin Pract 90 2010 167 172
12. A.F. Low, S.C. Seow, K.G. Yeoh, Y.T. Lim, H.C. Tan, and T.C. Yeo High-sensitivity C-reactive protein is predictive of medium-term cardiac outcome in high-risk Asian patients presenting with chest pain syndrome without myocardial infarction Ann Acad Med Singapore 33 2004 407 412
13. M.S. Paiva, C.V. Serrano Jr., and J.C. Nicolau Differences in the inflammatory response between patients with and those without diabetes mellitus after coronary stenting J Interv Cardiol 21 2008 403 409
14. O. Schnell, K.F. Braun, M. Müller, E. Standl, and W. Otter The Munich Myocardial Infarction Registry: impact of C-reactive protein and kidney function on hospital mortality in diabetic patients Diab Vasc Dis Res 7 2010 225 230
15. L.M. Biasucci, G. Liuzzo, and R. Della Bona Different apparent prognostic value of hsCRP in type 2 diabetic and nondiabetic patients with acute coronary syndromes Clin Chem 55 2009 365 368
16. S. Papaoikonomou, D. Tousoulis, and N. Tentolouris Assessment of the effects of the A3872G polymorphism on the C-reactive protein gene in patients with diabetes mellitus type 2 Int J Cardiol 151 2011 243 245
17. J. Spranger, A. Kroke, and M. Möhlig Inflammatory cytokines and the risk to develop type 2 diabetes results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study Diabetes 52 2003 812 817
18. J.K. Snell-Bergeon, N.A. West, and E.J. Mayer-Davis Inflammatory markers are increased in youth with type 1 diabetes: the SEARCH Case-Control study J Clin Endocrinol Metab 95 2010 2868 2876
19. T. Geisler, K. Mueller, and S. Aichele Impact of inflammatory state and metabolic control on responsiveness to dual antiplatelet therapy in type 2 diabetics after PCI: prognostic relevance of residual platelet aggregability in diabetics undergoing coronary interventions Clin Res Cardiol 99 2010 743 752
20. R. Pecoits-Filho, P. Bárány, B. Lindholm, O. Heimbürger, and P. Stenvinkel Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment Nephrol Dial Transplant 17 2002 1684 1688
21. C. Antoniades, D. Tousoulis, and K. Marinou Effects of insulin dependence on inflammatory process, thrombotic mechanisms and endothelial function, in patients with type 2 diabetes mellitus and coronary atherosclerosis Clin Cardiol 30 2007 295 300
22. H.E. Wasmuth, D. Kunz, and J. Graf Hyperglycemia at admission to the intensive care unit is associated with elevated serum concentrations of interleukin-6 and reduced ex vivo secretion of tumor necrosis factor-alpha Crit Care Med 32 2004 1109 1114
23. T. Nyström, A. Nygren, and A. Sjöholm Increased levels of tumour necrosis factor-alpha (TNF-alpha) in patients with type II diabetes mellitus after myocardial infarction are related to endothelial dysfunction Clin Sci (Lond) 110 2006 673 681
24. J.B. Meigs, F.B. Hu, N. Rifai, and J.E. Manson Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus JAMA 291 2004 1978 1986
25. N.T. Mulvihill, J.B. Foley, R.T. Murphy, G. Pate, P.A. Crean, and M. Walsh Enhanced endothelial activation in diabetic patients with unstable angina and non-Q-wave myocardial infarction Diabet Med 18 2001 979 983
26. C. Cardillo, U. Campia, M.B. Bryant, and J.A. Panza Increased activity of endogenous endothelin in patients with type II diabetes mellitus Circulation 106 2002 1783 1787
27. M. Yngen, C.G. Ostenson, H. Hu, N. Li, P. Hjemdahl, and N.H. Wallén Enhanced P-selectin expression and increased soluble CD40 Ligand in patients with type 1 diabetes mellitus and microangiopathy: evidence for platelet hyperactivity and chronic inflammation Diabetologia 47 2004 537 540
28. C.D. Stehouwer, M.A. Gall, J.W. Twisk, E. Knudsen, J.J. Emeis, and H.H. Parving Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death Diabetes 51 2002 1157 1165
29. B. Hohenstein, C.P. Hugo, B. Hausknecht, K.P. Boehmer, R.H. Riess, and R.E. Schmieder Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy Nephrol Dial Transplant 23 2008 1346 1354
30. J.B. Meigs, M.G. Larson, C.S. Fox, J.F. Keaney Jr., R.S. Vasan, and E.J. Benjamin Association of oxidative stress, insulin resistance, and diabetes risk phenotypes: the Framingham Offspring Study Diabetes Care 30 2007 2529 2535
31. F. Stam, C. van Guldener, C.G. Schalkwijk, P.M. ter Wee, A.J. Donker, and C.D. Stehouwer Impaired renal function is associated with markers of endothelial dysfunction and increased inflammatory activity Nephrol Dial Transplant 18 2003 892 898
32. U.N. Das, G. Repossi, A. Dain, and A.R. Eynard L-arginine, NO and asymmetrical dimethylarginine in hypertension and type 2 diabetes Front Biosci 16 2011 13 20
33. A. Fard, C.H. Tuck, and J.A. Donis Acute elevations of plasma asymmetric dimethylarginine and impaired endothelial function in response to a high-fat meal in patients with type 2 diabetes Arterioscler Thromb Vasc Biol 20 2000 2039 2044
34. G. Lippi, and M. Plebani Hyperhomocysteinemia in health and disease: where we are now, and where do we go from here? Clin Chem Lab Med 50 2012 2075 2080
35. M. Hoffman Hypothesis: hyperhomocysteinemia is an indicator of oxidant stress Med Hypotheses 77 2011 1088 1093
36. G.P. Fadini, M. Miorin, and M. Facco Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus J Am Coll Cardiol 45 2005 1449 1457
37. D.P. Bartel MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2004 281 297
38. V. Ambros The functions of animal microRNAs Nature 431 2004 350 355
39. M. Weber, M.B. Baker, J.P. Moore, and C.D. Searles MiR-21 is induced in endothelial cells by shear stress and modulates apoptosis and eNOS activity Biochem Biophys Res Commun 393 2010 643 648
40. F. Fleissner, V. Jazbutyte, and J. Fiedler Short communication: asymmetric dimethylarginine impairs angiogenic progenitor cell function in patients with coronary artery disease through a microRNA-21-dependent mechanism Circ Res 107 2010 138 143
41. A. Zampetaki, S. Kiechl, and I. Drozdov Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes Circ Res 107 2010 810 817
42. L. Kong, J. Zhu, and W. Han Significance of serum microRNAs in prediabetes and newly diagnosed type 2 diabetes: a clinical study Acta Diabetol 48 2011 61 69
43. P. Nehring, B. Mrozikiewicz-Rakowska, and A. Sobczyk-Kopcioł Osteoprotegerin gene rs2073617 and rs3134069 polymorphisms in type 2 diabetes patients and sexspecific rs2073618 polymorphism as a risk factor for diabetic foot Pol Arch Med Wewn 123 2013 176 182
44. G.B. Barra, L.A. Dutra, and S.C. Watanabe Association of the rs7903146 single nucleotide polymorphism at the Transcription Factor 7-like 2 (TCF7L2) locus with type 2 diabetes in Brazilian subjects Arq Bras Endocrinol Metabol 56 2012 479 484
45. A. Shoukry, S.M. Shalaby, and S. Abdelazim Endothelial nitric oxide synthase gene polymorphisms and the risk of diabetic nephropathy in type 2 diabetes mellitus Genet Test Mol Biomarkers 16 2012 574 579
46. D. Seelenfreund, S.R. Lobos, and A. Quesada Association of the intronic polymorphism rs891512 (G24943A) of the endothelial nitric oxide synthase gene with hypertension in Chilean type 2 diabetes patients Diabetes Res Clin Pract 96 2012 e47 e49
47. B.S. Cheema, H.S. Kohli, R. Sharma, A. Bhansali, and M. Khullar Endothelial nitric oxide synthase gene polymorphism and type 2 diabetic retinopathy among Asian Indians Acta Diabetol 49 2012 481 488
48. E. Shantsila, P.W. Kamphuisen, and G.Y. Lip Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis J Thromb Haemost 8 2010 2358 2368
49. M.E. Berman, and W.A. Muller Ligation of platelet/endothelial cell adhesion molecule 1 (PECAM-1/CD31) on monocytes and neutrophils increases binding capacity of leukocyte CR3 (CD11b/CD18) J Immunol 154 1995 299 307
50. S.R. Thom, M. Yang, V.M. Bhopale, S. Huang, and T.N. Milovanova Microparticles initiate decompression-induced neutrophil activation and subsequent vascular injuries J Appl Physiol 110 2011 340 351
51. S. Montoro-García, E. Shantsila, F. Marín, A. Blann, and G.Y. Lip Circulating microparticles: new insights into the biochemical basis of microparticle release and activity Basic Res Cardiol 106 2011 911 923
52. F.F. Hoyer, G. Nickenig, and N. Werner Microparticles - messengers of biological information J Cell Mol Med 14 2010 2250 2256
53. G. Tsimerman, A. Roguin, A. Bachar, E. Melamed, B. Brenner, and A. Aharon Involvement of microparticles in diabetic vascular complications Thromb Haemost 106 2011 310 321
54. K.H. Jung, K. Chu, and S.T. Lee Risk of macrovascular complications in type 2 diabetes mellitus: endothelial microparticle profiles Cerebrovasc Dis 31 2011 485 493
55. Y. Chen, B. Feng, X. Li, Y. Ni, and Y. Luo Plasma endothelial microparticles and their correlation with the presence of hypertension and arterial stiffness in patients with type 2 diabetes J Clin Hypertens (Greenwich) 14 2012 455 460
56. S. Bernard, R. Loffroy, and A. Sérusclat Increased levels of endothelial microparticles CD144 (VE-Cadherin) positives in type 2 diabetic patients with coronary noncalcified plaques evaluated by multidetector computed tomography (MDCT) Atherosclerosis 203 2009 429 435
57. C. Ersoy, S. Kiyici, and F. Budak The effect of metformin treatment on VEGF and PAI-1 levels in obese type 2 diabetic patients Diabetes Res Clin Pract 81 2008 56 60
58. J. De Jager, A. Kooy, and P. Lehert Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial J Intern Med 257 2005 100 109
59. G.P. Fadini, S.V. de Kreutzenberg, and V. Mariano Optimized glycaemic control achieved with add-on basal insulin therapy improves indexes of endothelial damage and regeneration in type 2 diabetic patients with macroangiopathy: a randomized crossover trial comparing detemir versus glargine Diabetes Obes Metab 13 2011 718 725
60. Z. Jankovec, D. Cechurova, M. Krcma, S. Lacigova, M. Zourek, and Z. Rusavy The influence of insulin pump treatment on metabolic syndrome parameters in type 2 diabetes mellitus Wien Klin Wochenschr 121 2009 459 463
61. P. Dandona, H. Ghanim, and A. Bandyopadhyay Insulin suppresses endotoxin-induced oxidative, nitrosative, and inflammatory stress in humans Diabetes Care 33 2010 2416 2423
62. P.A. Economides, A. Caselli, E. Tiani, L. Khaodhiar, E.S. Horton, and A. Veves The effects of atorvastatin on endothelial function in diabetic patients and subjects at risk for type 2 diabetes J Clin Endocrinol Metab 89 2004 740 747
63. R. Krysiak, A. Gdula-Dymek, and B. Okopien Effect of simvastatin and fenofibrate on cytokine release and systemic inflammation in type 2 diabetes mellitus with mixed dyslipidemia Am J Cardiol 107 2011 1010 1018
64. P.G. Fegan, A.C. Shore, D. Mawson, J.E. Tooke, and K.M. MacLeod Microvascular endothelial function in subjects with type 2 diabetes and the effect of lipid-lowering therapy Diabet Med 22 2005 1670 1676
65. S. Tehrani, F. Mobarrez, and A. Antovic Atorvastatin has antithrombotic effects in patients with type 1 diabetes and dyslipidemia Thromb Res 126 2010 e225 e231
66. S. Neri, S.S. Signorelli, and B. Torrisi Effects of antioxidant supplementation on postprandial oxidative stress and endothelial dysfunction: a single-blind, 15-day clinical trial in patients with untreated type 2 diabetes, subjects with impaired glucose tolerance, and healthy controls Clin Ther 27 2005 1764 1773
67. M.A. Haidara, H. Khloussy, H. Ammar, and L.A. Aal Kassem Impact of alpha-tocopherol and vitamin C on endothelial markers in rats with streptozotocin-induced diabetes Med Sci Monit 10 2004 BR41 BR46
68. T. Wago, T. Yoshimoto, and I. Akaza Improvement of endothelial function in patients with hypertension and type 2 diabetes after treatment with telmisartan Hypertens Res 33 2010 796 801
69. A.J. Flammer, F. Hermann, and P. Wiesli Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension J Hypertens 25 2007 785 791
70. M.T. Schram, F.J. van Ittersum, and A. Spoelstra-de Man Aggressive antihypertensive therapy based on hydrochlorothiazide, candesartan or lisinopril as initial choice in hypertensive type II diabetic individuals: effects on albumin excretion, endothelial function and inflammation in a double-blind, randomized clinical trial J Hum Hypertens 19 2005 429 437
71. A.M. Kampoli, D. Tousoulis, and Z. Pallanza Comparable effects of pioglitazone and peridopril on circulated endothelial progenitor cells, inflammation process in patients with diabetes mellitus Int J Cardiol 157 2012 413 415
72. P.J. Beisswenger, W.V. Brown, A. Ceriello IOOI Study Investigators Meal-induced increases in C-reactive protein, interleukin-6 and tumour necrosis factor α are attenuated by prandial + basal insulin in patients with type 2 diabetes Diabet Med 28 2011 1088 1095
73. D. Tousoulis, K. Koniari, and C. Antoniades Impact of 6 weeks of treatment with low-dose metformin and atorvastatin on glucose-induced changes of endothelial function in adults with newly diagnosed type 2 diabetes mellitus: a single-blind study Clin Ther 32 2010 1720 1728
74. A. Bellia, S. Rizza, and A. Galli Early vascular and metabolic effects of rosuvastatin compared with simvastatin in patients with type 2 diabetes Atherosclerosis 210 2010 199 201
75. A. Aversa, C. Vitale, and M. Volterrani Chronic administration of Sildenafil improves markers of endothelial function in men with type 2 diabetes Diabet Med 25 2008 37 44
76. A.J. Bank, A.S. Kelly, A.M. Thelen, D.R. Kaiser, and J.M. Gonzalez-Campoy Effects of carvedilol versus metoprolol on endothelial function and oxidative stress in patients with type 2 diabetes mellitus Am J Hypertens 20 2007 777 783
77. V. Martina, A. Masha, and V.R. Gigliardi Long-term N-acetylcysteine and L-arginine administration reduces endothelial activation and systolic blood pressure in hypertensive patients with type 2 diabetes Diabetes Care 31 2008 940 944
78. A. Chakraborty, S. Chowdhury, and M. Bhattacharyya Effect of metformin on oxidative stress, nitrosative stress and inflammatory biomarkers in type 2 diabetes patients Diabetes Res Clin Pract 93 2011 56 62
79. E. Karagiannis, A. Pfützner, and T. Forst The IRIS V study: pioglitazone improves systemic chronic inflammation in patients with type 2 diabetes under daily routine conditions Diabetes Technol Ther 10 2008 206 212
80. R. Pop-Busui, E. Oral, and D. Raffel Impact of rosiglitazone and glyburide on nitrosative stress and myocardial blood flow regulation in type 2 diabetes mellitus Metabolism 58 2009 989 994
81. S.M. Haffner, A.S. Greenberg, W.M. Weston, H. Chen, K. Williams, and M.I. Freed Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus Circulation 106 2002 679 684